Targeting a human protein may stop Ebola virus in its tracks
LA JOLLA, CA—To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus:
Promising antibody cocktail takes on Ebola virus—and its deadly cousin
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Shape-shifting Ebola virus protein exploits human RNA to change shape
New study highlights VP40 as a promising therapeutic target
Up and Coming: Haoyang Li, Ph.D. – An Inspired Vaccine
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
Saphire Lab
Erica Ollmann Saphire,
Ph.D.
President & Chief Executive Officer
Center for Infectious Disease and Vaccine Research
Erica Ollmann Saphire, Ph.D., studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
Building a world-class imaging facility
During the last week of August, the trucks finally started to arrive. Carefully nestled inside 22 huge wooden crates was
La Jolla Institute-led consortium awarded up to $35 million by NIH
LA JOLLA—La Jolla Institute Professor Erica Ollmann Saphire, Ph.D., will lead a five-year global effort totaling up to $35 million
San Diego Researchers Help With Urgent Effort To Stop Ebola In Africa
Erica Ollmann Saphire
“The beauty of structural biology is that it gives you the ability to dissect the molecular details at high resolution to explain precisely how something works."
Leading Structural Immunologist Erica Ollmann Saphire will join La Jolla Institute for Immunology
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) is honored to announce that Dr. Erica Ollmann Saphire, one of the